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Background: A significant number of patients visit dental clinics because of unusual oral sensations for which no
physical cause can be found. Such patients are recognized as having oral somatic delusion (OSD). OSD may be either
primary (monosymptomatic) or secondary to another disease, such as depression or cerebral infarction. Although the
presenting complaints of patients with primary and secondary OSD are nearly indistinguishable, symptoms in patients
with secondary OSD seem to be resistant to treatment compared with those in patients with primary OSD. Moreover,
right dominant cerebral blood flow (CBF) has been reported in patients with primary OSD, but the difference in CBF
between patients with primary and secondary OSD remains unclear. The aim of this study was to assess the differences
in clinical characteristics and CBF distribution between patients with monosymptomatic OSD (non-depression group)
and OSD in conjunction with remitted depression (depression group).
Methods: Participants were 27 patients of a psychosomatic dentistry clinic, all diagnosed with OSD. They were
categorized into either the non-depression group (17 patients) or the depression group (10 patients) on the basis
of assessments by their personal medical providers. CBF was examined using single-photon emission computed
tomography.
Results: There was no difference in clinical presentation between the two groups. A significant right dominant
asymmetry in the temporal and posterior cerebral regions was observed in both groups. In the central region, a right
dominance was seen in the non-depression group, while a left dominance was seen in the depression group.
Moreover, the mean regional CBF values for patients in the depression group were significantly lower in several
regions (including bilateral callosomarginal, precentral, angular, temporal, posterior cerebral, pericallosal, lenticular
nucleus, thalamus, and hippocampus; and right central and cerebellum) than for patients in the non-depression group.
Conclusion: These results suggest that the temporal and posterior cerebral regions are involved in in the
pathophysiology of OSD, regardless of depression history, and that widespread CBF reduction is a characteristic of
remitted depression.
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A significant number of patients who visit dental clinics
report unusual sensations in the oral area (e.g., sticky
or slimy saliva, the presence of foreign objects such as
sand, bubbles, eggs or metal pieces, and so on), but no
corresponding abnormality can be found on physical
examination. Such patients are recognized as having
oral somatic delusion (OSD), oral paresthesia, or oral
cenesthopathy.
Monosymptomatic OSD [1-3] is categorized as a delu-
sional disorder, somatic type (DDST) [4], but it some-
times appears secondary to a psychiatric disorder such
as schizophrenia or depression [5,6] or to cerebrovascu-
lar disease [7]. Most patients with monosymptomatic
OSD first visit a dental clinic because their cenestho-
pathic symptoms are limited to the oral cavity, convin-
cing them that there is a physical problem in that area.
Some patients with OSD are referred to dentists by their
psychiatrists because of oral cenesthopathic symptoms
that developed while their depression was in remission.
Because the chief complaints of patients with primary
and secondary OSD are very similar, it is difficult to dis-
tinguish between them on the basis of symptoms alone.
However, the symptoms of patients with secondary OSD
seem to be resistant to treatment compared with those
of patients with primary (monosymptomatic) OSD.
Several studies of regional cerebral blood flow (rCBF)
in patients with DDST have shown left temporal and
left parietal lobe hypoperfusion that normalized as the
symptoms improved [8-10]. We also previously re-
ported a case of OSD in which a rightward asymmetry
of blood flow in the temporal area disappeared after
successful treatment [2]. Furthermore, another of our
recent studies demonstrated that the CBF in patients
with OSD had a right > left asymmetry in the frontal
and temporal regions compared with the CBF of con-
trol patients [3]. Thus, a rightward asymmetry, espe-
cially in the temporal area, may be associated with the
development of cenesthopathy.
In the current study, we hypothesized that the clinical
features and the CBF distribution patterns in secondary
OSD, especially when it appears in the remitted period
of depression, are different from those in primary
(monosymptomatic) OSD.
With the aim of clarifying the differences between
primary (monosymptomatic) OSD and secondary OSD
associated with the remitted period of depression, we
investigated the clinical characteristics and the CBF dis-
tributions using single photon emission computed tom-
ography (SPECT).
Methods
This study involved 27 patients with OSD who visited
the psychosomatic dentistry clinic of Tokyo Medical andDental University dental hospital in Tokyo, Japan. All of
the subjects provided written informed consent. The ex-
clusion criteria were the presence of a delusion or hallu-
cination involving a body part other than the oral region,
abnormalities in magnetic resonance imaging findings, a
low Revised Hasegawa Dementia Scale (HDS-R) score
(<25) to exclude dementia, and the presence of other
neurological diseases, such as Parkinson’s disease. Because
of previous reports that pain causes changes in the CBF
[11-13], subjects with pain in their oral cavity or any other
body parts were also excluded.
Based on the results of patient interviews and assess-
ments by their attending doctors (including psychiatrists,
family physicians and other medical specialists), the sub-
jects were grouped as follows: non-depression group (no
history of psychiatric disorders) and depression group
(oral symptoms appeared during a remission period of a
major depressive disorder). For the subjects in the de-
pression group, all the subjects’ depressive states were
assessed as “remitted” or “very much improved” by their
psychiatrists.
The depressive state of each subject was assessed at
the time of the first examination using the Zung Self-
Rating Depression Scale (SDS). All subjects were right-
handed except subject No. 11.
Ethics statement
This study was conducted with the approval of the Eth-
ical Committee of Tokyo Medical and Dental University
(no. 356).
Demographic data
The demographic data for all subjects are listed in Tables 1
and 2. The non-depression group consisted of 17 subjects
(15 women, 2 men) with no history of psychiatric disor-
ders; the mean ± standard deviation (SD) age was 67.65 ±
10.33 years (range, 50–83 years). The depression group
consisted of 10 subjects (7 women, 3 men) who developed
OSD during a remission period of depression; the mean ±
SD age was 67.60 ± 6.59 years (range, 57–78 years).
Brain perfusion SPECT
SPECT imaging was performed with the subjects resting
and supine, with eyes closed and in quiet surroundings
after injection of a bolus of 600 MBq of Tc-99 m ethyl-
cysteinate dimer (99mTc-ECD) via the right brachial vein.
First, the passage from the heart to the brain was
monitored using a rectangular large-field dual-head
gamma camera (E.CAM Signature; Toshiba, Tokyo, Japan)
equipped with low-energy high-resolution parallel-hole
collimators. Data acquisition consisted of a sequence of
100 frames at a rate of 1 s/frame using a 128 × 128 matrix.
Next, SPECT images were obtained using the same
gamma camera equipped with fan-beam collimators. The
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Antipsychotics beeing











2 72 F 9 numerous “balloons” in a hole
in the palate




3 50 F 13 bubbles and a filmy substance
exuding from teeth







4 80 F 10 presence of something like
liquid exuding from her mandibular
reflux
esophagitis
- perospirone 12 mg,
sertraline 25 mg
44
5 64 M 18 presence of something like plastic ties







ethyl loflazepate 2 mg
24
6 76 F 9 sticky, glue-like substance in mouth none - aripiprazole 3 mg 29
7 83 F 26 garbage exuding from beneath
dentures; sticky and sandy mouth
prosthesis
(denture)
- aripiprazole 1.5 mg 56










etizolam 1.0 mg mirtazapine 15 mg 64
10 60 F 21 sticky mouth; sour and bitter taste; bubbles
and slimy substances persists around throat








12 70 F 23 movement of a dental implant and
balls in her mouth; pins coming
out through the night; sticky saliva
prosthesis
(denture)
- amitriptyline 30 mg 74
13 72 F 8 movement of a dental implant and
balls in her mouth; pins coming out
through the night; sticky saliva
prosthesis
(denture)
- ethyl loflazepate 1.5 mg 34
14 61 F 20 sticky mouth and too much saliva prosthesis - - 50
15 55 F 22 dental bridge feels too tight extraction - aripiprazole 1 mg 47
16 50 F 10 sticky mouth and salty-sweet taste none triazolam 0.125 mg aripiprazole 1 mg 46
17 60 F 54 sticy mouth and salty saliva prosthesis - - 33
SPECT: single-photon emission tomography.
SDS: Zung Self-Rating Depression Scale.
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shoot images were obtained throughout 180 degrees of ro-
tation (128 × 128 matrix, 1.72 mm/pixel) with an acquisi-
tion time of 30 s/step. All the images were reconstructed
using the ordered subset expectation maximization
method and were smoothed three-dimensionally using a
Butterworth filter. The Chang method was used to correct
for gamma ray attenuation.
Data analysis
For the regional CBF (rCBF) quantification, the Patlak
plot method [14,15] was applied to the 99mTc-ECDcerebral blood perfusion SPECT images to measure the
mean CBF (mCBF) of bilateral cerebral hemispheres.
Quantitative flow-mapping images were then obtained
from the qualitative cerebral perfusion SPECT images
using the Patlak plot graphical analysis and Lassen’s cor-
rection [16,17].
The rCBF quantification was performed using a three-
dimensional stereotactic regions of interest template
(3DSRT) program [18,19]. 3DSRT is a fully automated
rCBF quantification program that can be used to exam-
ine a total of 636 regions of interest (ROIs). These 636
ROIs are categorized into 12 brain segments on the
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mianserin 10 mg 50 remission
23 74 F 3 1 tasteless; substance resembling
frog eggs or pins persists over
tongue and membranes or fibers
present on labial mucosa;
sandy mouth
none sertraline 50 mg sertraline 50 mg 49 very much
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24 70 M 60 3 dry mouth; space in palate is too
full causing a chocking feeling
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improved
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25 58 M 34 6 metal substance extrudingt
from teeth; too much saliva
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parietal, angular, temporal, posterior cerebral, pericallo-
sal, lenticular nucleus, thalamus, hippocampal, and
cerebellar segments. The blood flow to each ROI was
quantified in mL/100 g/min.
For the analysis, the rCBF values obtained from the
3DSRT data and mCBF values obtained from the Patlak
Plot method were used. As an index of brain perfusion
asymmetry, the right to right + left ratio [R/(R + L) ratio]
was calculated for the 12 brain segments in each subject.
The R/(R + L) ratio equaled the rCBF values for the
target segment on the right side divided by the sum of
the rCBF values for the corresponding segments on the
right and left sides.
The mean rCBF values and the mean R/(R + L) ratios
for each brain segment and the mCBF values for global
and for right and left hemispheres were calculated separ-
ately for the non-depression and the depression group.
The results were expressed as the mean ± SD.
Statistical analysis
PASW 17.0 software (IBM, Chicago, IL, USA) was used
to perform the Mann–Whitney U test and the Pearson’s
χ2 test. All the tests were two-tailed, and P values < 0.05
were considered statistically significant.
Results
Clinical features of patients in non-depression and
depression groups
Tables 1 and 2 show the demographic and clinical data
of the OSD patients involved in the present study. No
significant differences in age (P = 0.639) or sex (P =
0.239) were observed between the non-depression and
the depression groups. In our previous report [3], the
subjects were also predominantly female (6 women, 2
men), but the mean ± SD age was 75.9 ± 6.0 years, which
is older than the subjects in the present study.
As shown in Tables 1 and 2, the chief complaints in
both groups were similar: “sticky or slimy saliva”, “for-
eign body sensation”, “bitter or sour taste”, or “some-
thing resembling bubbles, pieces of metal, or plastic”.
The duration of illness in the depression group was
27.14 ± 20.52 months (range, 3–81 months), which was
longer than that in the non-depression group (22.35 ±
15.18 months; range, 8–56 months). However, the differ-
ence was not significant (P = 0.309). Despite the long
duration of symptoms, all the subjects continued to
socialize. In the depression group, the mean time from
onset of depression to onset of OSD varied (6.70 ±
5.76 years; range, 1–18 years), but all of the subjects
were in the remission period of depression when the
OSD appeared, according to the assessments made by
their psychiatrists. In the depression group, the medica-
tions that were being taken at the time of the firstexamination were mainly anxiolytics or hypnotics, and
some patients were not taking any antidepressant at all.
Regarding the SDS score, the mean score in the non-
depression group (43.9 ± 14.4) was somewhat higher
than that in the depression group (38.9 ± 7.26), but the
difference was not statistically significant (P = 0.245). No
apparent difference was observed in any clinical charac-
teristic categories between the non-depression and de-
pression groups.
Difference in rCBF between non-depression and
depression groups
Table 3 shows the mean rCBF values for the 24 seg-
ments in each of the groups. In the non-depression
group, a right dominant asymmetry was observed for
many segments, especially the temporal, posterior cere-
bral, and cerebellum (where significant differences were
observed). In the depression group, a significant right
dominant asymmetry was observed in the temporal and
posterior cerebral. Furthermore, in the depression group,
the central region showed a significant left dominant
asymmetry. We examined and compared the R/(R + L)
ratio in each region for both groups (Figure 1). A right
dominant asymmetry was observed in many regions in
both the non-depression and depression groups. How-
ever, a significant difference between the non-depression
and depression groups was observed only for the central
region, with a right dominant asymmetry observed in
the non-depression group and a left dominant asym-
metry observed in the depression group.
Figure 2 shows the difference in the mean rCBF values
between the non-depression and depression groups.
Analysis of each segment revealed that the mean rCBF
values in the depression group were significantly lower
than those of the non-depression group in the bilateral
callosomarginal and precentral; right central; bilateral
angular, temporal, posterior cerebral, pericallosal, len-
ticular nucleus, thalamus, and hippocampus; and right
cerebellum. Moreover, because the rCBF patterns in
both groups were similar, these reductions were not par-
tial but were total and even. To confirm these global
CBF reductions in the depression group, the mCBF
values measured by the Patlak Plot method also com-
pared the two groups. The mCBF values in the depres-
sion group were significantly lower in the global (P =
0.0045) and the right (P = 0.0014) and left (P = 0.0011)
hemispheres than those in the non-depression group
(Figure 3).
Effects of medications on mCBF values
As listed in Table 1, 15/17 patients in the non-depression
group and 10/10 patients in the depression group were
taking psychotropics (antipsychotics, antidepressants,
or anxiolytics) or hypnotics at the time of SPECT
Table 3 Mean rCBF values for 24 segments in the
non-depression and depression groups
Right hemisphere Left hemisphere P value
non-depression group
callosomarginal 43.9 ± 3.82 43.56 ± 4.19 0.156
precentral 46.41 ± 4.18 45.44 ± 4.62 0.114
central 44.61 ± 3.54 43.98 ± 3.99 0.198
parietal 44.28 ± 4.03 42.94 ± 4.07 0.056
angular 46.92 ± 4.96 45.54 ± 3.90 0.097
temporal 43.74 ± 3.34 41.99 ± 3.44 0.012*
posteriorcerebral 48.34 ± 3.85 47.41 ± 3.87 0.042*
pericallosal 46.74 ± 4.16 46.43 ± 4.52 0.115
lenticular nucleus 50.13 ± 4.58 49.39 ± 4.54 0.260
thalamus 46.94 ± 5.33 46.15 ± 4.66 0.218
hippocampus 37.74 ± 4.02 37.81 ± 4.31 0.876
cerebellum 55.67 ± 5.61 54.42 ± 6.34 0.018*
depression group
callosomarginal 39.19 ± 4.33 39.28 ± 4.40 0.564
precentral 41.78 ± 5.22 41.12 ± 4.39 0.344
central 40.71 ± 4.42 41.55 ± 4.03 0.030*
parietal 39.84 ± 5.14 39.27 ± 4.49 0.366
angular 40.71 ± 4.30 40.56 ± 4.61 0.887
temporal 38.26 ± 3.30 36.96 ± 2.83 0.027*
posteriorcerebral 44.50 ± 3.71 43.80 ± 3.46 0.016*
pericallosal 42.14 ± 4.68 41.93 ± 4.30 0.355
lenticular nucleus 45.00 ± 3.12 44.63 ± 2.74 0.229
thalamus 41.03 ± 4.35 39.58 ± 4.39 0.186
hippocampus 33.82 ± 2.51 33.56 ± 2.43 0.662
cerebellum 51.11 ± 4.21 50.35 ± 4.72 0.142
*; P < 0.05.
In the non-depression group, significant right dominant asymmetries were
observed in the temporal, posterior cerebral, and cerebellum. In the depression
group, a significant left dominant asymmetry was observed in the central, and
significant right dominant asymmetries were observed in the temporal and
posterior cerebral.
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vary widely, this factor is difficult to standardize. We
concentrated on the use of antidepressants, which were
taken by the largest number of subjects, and standard-
ized the data using an imipramine equivalent [20]
(Table 4). No significant difference in the imipramine
equivalent dose was observed between the non-depression
and depression groups (P = 0.155). The number of patients
taking antidepressants was 8/17 in the non-depression
group and 8/10 in the depression group. Focusing on only
the patients who were taking antidepressants, the mCBF
value in the depression group was significantly lower than
that in the non-depression group (8 patients in each
group; global P = 0.050; left hemisphere P = 0.038, right
hemisphere P = 0.021), with no significant difference inthe imipramine equivalent doses (P = 0.959). Within the
non-depression group, the mCBF value in the 8 patients
taking antidepressants was slightly lower than that in the
9 patients who were not taking antidepressants, although
the difference was not significant (global P = 0.167; left
hemisphere P = 0.236; right hemisphere P = 0.321).
Discussion
The present study had two principal findings. First, no
apparent clinical symptomatic difference was observed
between the pure and depression groups, and a right
dominant asymmetry was observed in the temporal and
posterior cerebral in both groups. On the other hand, in
the central, a significant difference was observed be-
tween both groups: a left dominant asymmetry was ob-
served in the depression group, while a right dominant
asymmetry was observed in the pure group.
Second, the mean rCBF values in the depression group
were significantly lower than those in the pure group in
many regions. Moreover, in the depression group, the
mean mCBF values in the global, and the right and left
hemispheres were also significantly lower than those in
the pure group.
Right dominant asymmetry in OSD
A right dominant asymmetry was observed in the non-
depression group, but the asymmetry was not as prom-
inent as that in our previous report [3]. The reason for
this difference might have been the different characteris-
tics and number of subjects in the two studies. Because
the results of our previous study suggested that OSD has
various subtypes, patients with cenesthopathic symp-
toms in other body parts or who were experiencing pain
were excluded from the present study. Such careful
screening to select more homogeneous OSD might have
contributed to the difference in the results between the
present study and our previous study. The difference in
the mean age might also have contributed to the differ-
ence in the degree of asymmetry. However, a significant
right dominant asymmetry in the temporal region was
common to both the present and our previous studies.
Our previous case report [2] showed a right dominant
asymmetry in the temporal region that became less
marked after an improvement in the symptoms of OSD.
Therefore, the temporal region might play an important
role in the pathophysiology of OSD. Moreover, since the
right dominant asymmetry in the temporal region was
found in not only the non-depression group but also in
the depression group, the temporal region might be in-
volved in the pathophysiology of OSD regardless of the
history of depression. On the other hand, no previous
report about the right dominant asymmetry in the pos-
terior cerebral was found. Based on the results of this
study, the posterior cerebral as well as the temporal
Figure 1 Mean R/(R + L) ratio for each segment. A significant difference was observed in the central: a right dominant asymmetry was observed in
the non-depression group, and a left dominant asymmetry was observed in the depression group.
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OSD; however, further studies are necessary to confirm
this theory.
In the central, a significant difference was observed be-
tween the non-depression and depression groups: right
dominance was observed in the non-depression group,
while left dominance was observed in the depression
group. This result suggests that the central region, in-
cluding the central sulcus, which is well known as aFigure 2 Mean regional cerebral blood flow values for 24 segments in
significantly lower in all segments except the left central, bilateral parietal, andsomatosensory and motor area, is involved in the patho-
physiology of OSD. Further investigations are expected.
Global reduction in CBF in the depression group
Mean rCBF values of the depression group were sig-
nificantly lower than those of the non-depression
group in several regions, and the mCBF values were
also significantly lower in the global and the right and
left hemispheres.each group. The mean rCBF values in the depression group were
cerebellum, compared with the values in the non-depression group.
Figure 3 Mean regional cerebral blood flow values for global and the left and right hemispheres. All the mCBF values in the depression
group were significantly lower than those in the non-depression group.
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group showed abnormal perfusion is unknown, since
they were not compared with non-OSD controls. How-
ever, in our previous study [3], the absolute CBF values
in subjects with OSD (8 cases) were somewhat higher
than those of subjects without OSD (8 cases), although
the difference was not significant. Therefore, a global
CBF decrease in the depression group may be a more
likely explanation for the differences than a CBF increase
in the non-depression group.
The reasons for these CBF reductions should be care-
fully examined from several aspects.
Effects of medications on mCBF values
The first reason that should be considered is the effect
of medications. Some medications, including antide-
pressants, antipsychotics, anxiolytics, and hypnotics, re-




non-depression group total (n = 17) 38.53 ± 65.57
taken antidepressants (n = 8) 81.88 ± 75.97
no antidepressants (n = 9) 0
depression group total (n = 10) 58.50 ± 51.91
taken antidepressants (n = 8) 73.13 ± 47.35
no antidepressants (n = 2) 0
No difference in the imipramine equivalent doses was observed between the non-d
observed between subjects taking and not taking antidepressants. However, focusin
depression group was significantly lower than that in the non-depression group.However, the results in this study suggest that the effect
of medications is not sufficient to explain the CBF re-
duction observed in widespread regions in the depres-
sion group, even when the data is partially corrected
for medication use.
Effects of depression itself on the mCBF values
Another reason that should be considered is the effect
of depression itself. The theory that CBF may be widely
decreased by of comorbid depression is fascinating.
There are many previous studies of CBF in depressive
patients. Some reported a total reduction [24-26], which
is similar to the results of the present study, but others
reported regional reductions in the frontal, temporal, or
parietal regions [27-29]. Because of such varied and in-
consistent results, CBF changes in depression are still
unclear. On the other hand, remitted depression has also
been studied with regard to several factors includingipramine equivalent doses
ose
mCBF values
Whole brain Left hemisphere Right hemisphere
43.15 ± 2.85 43.31 ± 2.78 43.45 ± 2.46
42.43 ± 3.59 42.60 ± 3.51 42.91 ± 3.19
43.79 ± 2.00 43.93 ± 1.93 43.93 ± 1.64
39.10 ± 2.89 39.03 ± 2.82 39.02 ± 3.10
38.71 ± 3.03 38.70 ± 2.91 38.44 ± 3.21
40.65 ± 2.19 40.35 ± 2.76 41.35 ± 0.78
epression and depression groups. No difference in the mCBF values was
g on only the patients who took antidepressants, the mCBF value in the
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without depression have been found, even though the
subjects with depression were assessed as being clinically
remitted [30-32].
In the present study, the subjects in the depression
group were assessed as having improved or remitted de-
pression based on referral letters from their psychiatrists
rather than on rigorous standards of remission in de-
pression [33,34]. However, the small doses of medication
that were being taken and the relatively low SDS scores
suggest that subjects in the depression group would
likely be categorized as having strictly defined remitted
depression.
Taken together, the widespread reduction in CBF ob-
served in the depression group in the present study
might reflect the vulnerability of subjects with remitted
or almost-remitted depression.
There were three limitations of the present study. The
first was that almost all subjects were taking medications
at the time of SPECT examination. No significant differ-
ence was found in the imipramine equivalent doses;
however, other medications (such as antipsychotics, an-
xiolytics, or hypnotics) and their interactions could
affect the CBF. The second limitation was that the de-
pressive states of subjects were not assessed by rigorous
standards of remission in depression. The third limita-
tion was the small number of subjects, especially in the
depression group. To examine statistical significance
with adequate dependability, more studies with a larger
number of subjects are necessary.
Regardless of the careful screening to select more
homogeneous OSD, subjects of this study still exhibited
a range of clinical characteristics and CBF distribution
patterns. Further studies using more subjects from many
different clinical aspects are needed to clarify the diver-
sity and pathophysiology of OSD.
Conclusions
In conclusion, in the present study, no clinical symptom-
atic difference was observed, and a significant right
dominant asymmetry in the temporal and posterior cere-
bral regions was found in subjects both with monosymp-
tomatic (primary) OSD and with OSD associated with
remitted depression. Moreover, CBF in the depression
group was significantly decreased in widespread regions,
compared with that in the non-depression group. This
phenomenon might reflect medication use, but it is
more likely that widespread CBF reduction is a charac-
teristic of remitted depression.
To clarify the pathophysiology of OSD, further studies
using more subjects and details are needed.
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